ABO-mismatched platelet transfusions: Strategies to mitigate patient exposure to naturally occurring hemolytic antibodies

Transfusion and Apheresis Science

Volumn 42, Issue 1, 2010, Pages 83-88

  Josephson, Cassandra D ^a,b,c   Castillejo, Marta Inés ^a,b,c   Grima, Kathleen ^d   Hillyer, Christopher D ^d  

^a Center for Transfusion and Cellular Therapies   (United States)

^b Blood and Tissue Services ^*  (United States)

^c AFLAC   (United States)

^d NEW YORK BLOOD CENTER   (United States)

Author keywords

ABO incompatible platelets; Hemolytic transfusions

Indexed keywords

HEMAGGLUTININ;

ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP O; BLOOD TRANSFUSION REACTION; CLINICAL PRACTICE; HEALTH CARE POLICY; HUMAN; PROPHYLAXIS; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; ANEMIA, HEMOLYTIC; BLOOD BANKS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; CHILD; CHILD, PRESCHOOL; EUROPE; HEALTH POLICY; HEMAGGLUTININS; HEMOLYSIS; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, ACUTE; MIDDLE AGED; PLASMA; PLATELET TRANSFUSION; SHOCK; UNITED STATES; YOUNG ADULT;

EID: 75949101859     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2009.10.013     Document Type: Article

References (46)

1. Cooling L. ABO and platelet transfusion therapy. Immunohematology 23 (2007) 20-33
2. Fung M.K., Downes K.A., and Shulman I.A. Transfusion of platelets containing ABO-incompatible plasma. Arch Pathol Lab Med 131 (2007) 909-916
3. Harris S.B., Josephson C.D., Kost C.B., and Hillyer C.D. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A. Transfusion 47 (2007) 1412-1417
4. Mair B., and Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion 38 (1998) 51-55
5. Larsson L.G., Welsh V.J., and Ladd D.J. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 40 (2000) 902-906
6. Garratty G. Problems associated with passively transfused blood group alloantibodies. Am J Clin Pathol 109 (1998) 769-777
7. Kelton J.G., Hamid C., Aker S., and Blajchman M.A. The amount of blood group A substance on platelets is proportional to the amount in the plasma. Blood 59 (1982) 980-985
8. Dunstan R.A., Simpson M.B., Knowles R.W., and Rosse W.F. The origin of ABH antigens on human platelets. Blood 65 (1985) 615-619
9. Duquesnoy R.J., Anderson A.J., Tomasulo P.A., and Aster R.H. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood 54 (1979) 595-599
10. Heal J.M., Blumberg N., and Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 70 (1987) 23-30
11. Heal J.M., Rowe J.M., McMican A., Masel D., Finke C., and Blumberg N. The role of ABO matching in platelet transfusion. Eur J Haematol 50 (1993) 110-117
12. Lee E.J., and SChiffer C.A. ABO compatibility can influence the results of platelet transfusion: results of a randomized trial. Transfusion 29 (1989) 384-389
13. Carr R., Hutton J.L., Jenkins J.A., Lucas G.F., and Amphlett N.W. Transfusion of ABO mismatched platelets leads to early platelet refractoriness. Br J Haematol 75 (1990) 408-413
14. Simon T.L., and Sierra E.R. Concentration of platelet units into small volumes. Transfusion 24 (1984) 173-175
15. Moroff G., Friedman A., Robkin-Kline L., et al. Reduction of the volume of stored platelet concentrates for use in neonatal patients. Transfusion 24 (1984) 144-146
16. Lozano M., and Cid J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 17 (2003) 57-68
17. Murphy M.F., Hook S., Waters A.H., et al. Acute haemolysis after ABO-incompatible platelet transfusion. Lancet 335 (1990) 974-975
18. Aubert E.F., Boorman K.E., Dodd B.E., and Loutit J.F. The universal donor with high titre iso-agglutinins: the effect of anti-A iso-agglutinins on recipients of group A. BMJ 1 (1942) 659-664
19. Tisdall L.H., Garland D.M., Szanto P.B., Hand A.M., and Bonnett J.C. The effects of high isoagglutinin titer into recipients of other blood groups. Am J Clin Pathol 16 (1946) 193-206
20. Ebert R.V., and Emerson C.P. A clinical study of transfusion reactions: the hemolytic effect of group-O blood and pooled plasma containing incompatible isoagglutinins. J Clin Invest 25 (1946) 627-638
21. Josephson C.D., Mullis N.C., Van Demark C., et al. Significant numbers of apheresis-derived group O platelet units have a "high-titer" anti-A/A, B: implications for transfusion policy. Transfusion 44 (2004) 805-808
22. Sadani D.T., Urbaniak S.J., Bruce M., and Tighes J.E. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med 16 (2006) 375-379
23. Standards for Blood Banks and Transfusion Services, Standard 5.14.4. 24th ed. Bethesda, MD: AABB; 2006. p. 40.
24. Commission on Laboratory Accreditation. Transfusion medicine checklist, TRM.40700 and TRM.40740. Laboratory accreditation program. Northfield, Ill: College of American Pathologists; December 2004.
25. Conway L.T., and Scott E.P. Acute hemolytic transfusion reaction due to ABO incompatible plasma in a plateletpheresis concentrate. Transfusion 24 (1984) 413-414
26. Pierce R.N., Reich L.M., and Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion 25 (1985) 60-62
27. Chow M.P., Yung C.H., Hu H.Y., et al. Hemolysis after ABO-incompatible platelet transfusions. Chin Med J (Taipei) 48 (1991) 131-134
28. Duguid J.K.M., Minards J., and Bolton-Maggs P.H.B. Incompatible plasma transfusions and haemolysis in children. BMJ 318 (1999) 176-177
29. Valbonesi M., Deluigi M.C., Lercari G., et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs 23 (2000) 642-646
30. Angiolillo A., and Luban N.L.C. Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans Cell Histiocytosis. J Pediatr Hematol Oncol 26 (2004) 267-269
31. MacLennan S. High titre anti-A/B testing of donors within the National Blood Service (NBS) (Internet). London: NBS; 2002 February, Available from http://www.blood.co.uk/hospitals/guidelines/pdf/hightit.pdf.
32. Sapatnekar S., Sharma G., Downes K.A., Wiersma S., McGrath C., and Yomtovian R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apher 20 (2005) 225-229
33. Novotny V.M.J., and Brand A. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang 88 (2005) 215-216
34. Reinhardt P., Wiesneth M., Schrezenmeier H., and Seifried E. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang 88 (2005) 212-213
35. Lundberg W.B., and McGinnisss M.H. Hemolytic transfusion reaction due to anti-A. Transfusion 15 (1975) 1-9
36. Zoes C., Dube V.E., Miller H.J., and Vye M.V. Anti-A1 in the plasma of platelet concentrates causing hemolytic reaction. Transfusion 17 (1977) 29-32
37. McLeod B.C., Sassetti R.J., Weens J.H., and Vaithianathan T. Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrate. Scand J Haematol 28 (1982) 193-196
38. Siber G.R., Ambrosino D.M., and Gorgone B.C. Blood-group-A-like substance in a preparation of pneumococcal vaccine. Ann Int Med 96 (1982) 580-586
39. Ferguson D.J. Acute intravascular hemolysis after a platelet transfusion. CMAJ 138 (1988) 523-524
40. Reis M.D., and Coovadia A.S. Transfusion of ABO-incompatible platelets causing severe haemolytic reaction. Clin Lab Haematol 11 (1989) 237-240
41. The Serious Hazards of Transfusion Steering Group. Serious hazards of transfusion (SHOT) 1998-1999 annual report (UK). Manchester, United Kingdom: SHOT Office; 2000, Available at http://www.shot.demon.co.uk/shot%20report%201998-99.html [accessed 2.10.09].
42. McManigal S., and Sims K.L. Intravascular hemolysis secondary to ABO incompatible platelet products: underrecognized transfusion reaction. Am J Clin Pathol 111 (1999) 202-206
43. The Serious Hazards of Transfusion Steering Group. Serious hazards of transfusion (SHOT) 2000-2001 annual report (UK). Manchester, United Kingdom: SHOT Office, Available at http://www.shotuk.org/shot%20report%2000-01.pdf; 2002 [accessed 2.10.09].
44. The Serious Hazards of Transfusion Steering Group. Serious Hazards of Transfusion (SHOT) 2003 annual report (UK). Manchester, United Kingdom: SHOT Office, Available at http://www.shotuk.org/shot%20report%202003.pdf; 2004 [accessed 2.10.09].
45. MacLennan S. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang 88 (2005) 218-219
46. Fauzie D., Shirey R.S., Thoman S., Bensen-Kennedy D., and King K.E. The risk of hemolytic transfusion reactions due to passively-acquired ABO antibodies: a retrospective study of non-group O adult recipients of group O plateletpheresis transfusions. Transfusion 44 Suppl. (2004) 36A [abstract]